taurine has been researched along with Inflammatory Bowel Diseases in 10 studies
Inflammatory Bowel Diseases: Chronic, non-specific inflammation of the GASTROINTESTINAL TRACT. Etiology may be genetic or environmental. This term includes CROHN DISEASE and ULCERATIVE COLITIS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The taurine-treated animals showed reduced MPO activity (35% lower) when compared with that of the vehicle-treated animals." | 1.30 | Taurine can ameliorate inflammatory bowel disease in rats. ( Kang, HK; Kim, BK; Kim, WB; Ko, JI; Son, M, 1998) |
| "The taurine-treated animals significantly reduced MPO activity (35% lower) when compared with that of the vehicle-treated animals." | 1.30 | Protective effect of taurine on TNBS-induced inflammatory bowel disease in rats. ( Doh, HM; Kim, BK; Kim, WB; Ko, JI; Park, TS; Shim, MJ; Son, MW, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (20.00) | 18.2507 |
| 2000's | 1 (10.00) | 29.6817 |
| 2010's | 5 (50.00) | 24.3611 |
| 2020's | 2 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhuang, Z | 1 |
| Li, N | 1 |
| Wang, J | 1 |
| Yang, R | 1 |
| Wang, W | 1 |
| Liu, Z | 1 |
| Huang, T | 1 |
| Bushman, FD | 1 |
| Conrad, M | 1 |
| Ren, Y | 1 |
| Zhao, C | 1 |
| Gu, C | 1 |
| Petucci, C | 1 |
| Kim, MS | 1 |
| Abbas, A | 1 |
| Downes, KJ | 1 |
| Devas, N | 1 |
| Mattei, LM | 1 |
| Breton, J | 1 |
| Kelsen, J | 1 |
| Marakos, S | 1 |
| Galgano, A | 1 |
| Kachelries, K | 1 |
| Erlichman, J | 1 |
| Hart, JL | 1 |
| Moraskie, M | 1 |
| Kim, D | 1 |
| Zhang, H | 1 |
| Hofstaedter, CE | 1 |
| Wu, GD | 1 |
| Lewis, JD | 1 |
| Zackular, JP | 1 |
| Li, H | 1 |
| Bittinger, K | 1 |
| Baldassano, R | 1 |
| Barclay, ML | 1 |
| Stamp, LK | 1 |
| Alhouayek, M | 1 |
| Bottemanne, P | 1 |
| Subramanian, KV | 1 |
| Lambert, DM | 1 |
| Makriyannis, A | 1 |
| Cani, PD | 1 |
| Muccioli, GG | 1 |
| Levy, M | 1 |
| Thaiss, CA | 1 |
| Zeevi, D | 1 |
| Dohnalová, L | 1 |
| Zilberman-Schapira, G | 1 |
| Mahdi, JA | 1 |
| David, E | 1 |
| Savidor, A | 1 |
| Korem, T | 1 |
| Herzig, Y | 1 |
| Pevsner-Fischer, M | 1 |
| Shapiro, H | 1 |
| Christ, A | 1 |
| Harmelin, A | 1 |
| Halpern, Z | 1 |
| Latz, E | 1 |
| Flavell, RA | 1 |
| Amit, I | 1 |
| Segal, E | 1 |
| Elinav, E | 1 |
| Van den Bossche, L | 1 |
| Hindryckx, P | 1 |
| Devisscher, L | 1 |
| Devriese, S | 1 |
| Van Welden, S | 1 |
| Holvoet, T | 1 |
| Vilchez-Vargas, R | 1 |
| Vital, M | 1 |
| Pieper, DH | 1 |
| Vanden Bussche, J | 1 |
| Vanhaecke, L | 1 |
| Van de Wiele, T | 1 |
| De Vos, M | 1 |
| Laukens, D | 1 |
| Shimizu, M | 1 |
| Zhao, Z | 1 |
| Ishimoto, Y | 1 |
| Satsu, H | 1 |
| Devkota, S | 1 |
| Wang, Y | 1 |
| Musch, MW | 1 |
| Leone, V | 1 |
| Fehlner-Peach, H | 1 |
| Nadimpalli, A | 1 |
| Antonopoulos, DA | 1 |
| Jabri, B | 1 |
| Chang, EB | 1 |
| Son, M | 1 |
| Ko, JI | 2 |
| Kim, WB | 2 |
| Kang, HK | 1 |
| Kim, BK | 2 |
| Son, MW | 1 |
| Doh, HM | 1 |
| Park, TS | 1 |
| Shim, MJ | 1 |
10 other studies available for taurine and Inflammatory Bowel Diseases
| Article | Year |
|---|---|
GWAS-associated bacteria and their metabolites appear to be causally related to the development of inflammatory bowel disease.
Topics: Bacteria; Betaine; Colitis, Ulcerative; Crohn Disease; Genome-Wide Association Study; Humans; Inflam | 2022 |
Multi-omic Analysis of the Interaction between Clostridioides difficile Infection and Pediatric Inflammatory Bowel Disease.
Topics: Adolescent; Biomarkers; Caproates; Child; Clostridioides difficile; Clostridium Infections; DNA, Bac | 2020 |
Editorial: vedolizumab as a treatment and cause of extra-intestinal manifestations of inflammatory bowel disease.
Topics: Animals; Antibodies, Monoclonal, Humanized; Cattle; Humans; Hypertension, Portal; Inflammatory Bowel | 2018 |
N-Acylethanolamine-hydrolyzing acid amidase inhibition increases colon N-palmitoylethanolamine levels and counteracts murine colitis.
Topics: Amides; Amidohydrolases; Animals; Anti-Inflammatory Agents; Arachidonic Acids; Chromatography, High | 2015 |
Microbiota-Modulated Metabolites Shape the Intestinal Microenvironment by Regulating NLRP6 Inflammasome Signaling.
Topics: Animals; Antimicrobial Cationic Peptides; Colitis; Colon; Dysbiosis; Germ-Free Life; Inflammasomes; | 2015 |
Ursodeoxycholic Acid and Its Taurine- or Glycine-Conjugated Species Reduce Colitogenic Dysbiosis and Equally Suppress Experimental Colitis in Mice.
Topics: Animals; Bacteroides; Colon; Dextran Sulfate; Disease Models, Animal; Dysbiosis; Feces; Firmicutes; | 2017 |
Dietary taurine attenuates dextran sulfate sodium (DSS)-induced experimental colitis in mice.
Topics: Animals; Dextran Sulfate; Diet; Disease Models, Animal; Inflammatory Bowel Diseases; Interleukin-8; | 2009 |
Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10-/- mice.
Topics: Animals; Bile Acids and Salts; Bilophila; Colitis; Diet, Fat-Restricted; Dietary Fats; Inflammation; | 2012 |
Taurine can ameliorate inflammatory bowel disease in rats.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Colon; Disease Models, Animal; Eicosanoids; Inflam | 1998 |
Protective effect of taurine on TNBS-induced inflammatory bowel disease in rats.
Topics: Animals; Colitis; Colon; Dinoprostone; Eicosanoids; Inflammatory Bowel Diseases; Luminescent Measure | 1998 |